Sotera Health Appoints Kenneth D. Krause to the Board of Directors
Globe Newswire (Mon, 16-Mar 7:00 AM ET)
Sotera Health Launches 25 Million Share Secondary Offering—Key Takeaways for Investors
Market Chameleon (Thu, 5-Mar 2:59 AM ET)
Sotera Health Announces Secondary Offering of Common Stock
Globe Newswire (Wed, 4-Mar 4:51 PM ET)
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Globe Newswire (Tue, 24-Feb 7:00 AM ET)
Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date
Globe Newswire (Tue, 17-Feb 7:30 AM ET)
Sotera Health Appoints Richard Kyle to the Board of Directors
Globe Newswire (Thu, 5-Feb 7:30 AM ET)
Globe Newswire (Mon, 12-Jan 7:00 AM ET)
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globe Newswire (Wed, 7-Jan 7:30 AM ET)
Market Chameleon (Fri, 7-Nov 4:03 AM ET)
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Sotera Health Company trades on the NASDAQ stock market under the symbol SHC.
As of March 26, 2026, SHC stock price declined to $13.54 with 1,508,817 million shares trading.
SHC has a beta of 1.49, meaning it tends to be more sensitive to market movements. SHC has a correlation of 0.31 to the broad based SPY ETF.
SHC has a market cap of $3.85 billion. This is considered a Mid Cap stock.
Last quarter Sotera Health Company reported $303 million in Revenue and $.26 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.03.
In the last 3 years, SHC traded as high as $19.85 and as low as $9.53.
The top ETF exchange traded funds that SHC belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.
SHC has outperformed the market in the last year with a price return of +13.5% while the SPY ETF gained +13.4%. However, in the short term, SHC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -23.5% vs -6.3% return in SPY. But in the last 2 weeks, SHC shares have fared better than the market returning -2.7% compared to SPY -4.4%.
SHC support price is $13.38 and resistance is $14.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SHC shares will trade within this expected range on the day.